JIUYUAN GENE (02566) proposes appointing Huang Wenli as an independent non-executive director.

01:24 31/03/2026

Jiuyuan Genetics (02566) announced that the board of directors recommended the appointment of Dr. Huang Wenli as an independent non-executive director, and recommended that the appointment of independent non-executive directors shall take effect from the date approved by the shareholders at the annual general meeting of shareholders and expire at the end of the first term of the board of directors.

JIUYUAN GENE (02566) announced that the Board of Directors recommended the appointment of Dr. Huang Wenli as an independent non-executive director. It is recommended that the appointment of independent non-executive directors shall take effect from the date approved by the shareholders at the annual general meeting and shall last until the expiration of the first term of the board of directors.

BBSB INTL (08610) reported an annual net profit attributable to shareholders of 6.289 million Ringgit, a decrease of 75.99% year-on-year.

XINHUA LANDE (08106) releases its financial performance for the year 2025, with a net profit of 108.7 million yuan.

Yik Wo International (08659) announces financial performance for 2025. The attributable loss for the year is expected to be approximately 6.773 million yuan, a year-on-year change from profit to loss.

BBSB INTL (08610) reported an annual net profit attributable to shareholders of 6.289 million Ringgit, a decrease of 75.99% year-on-year.

XINHUA LANDE (08106) releases its financial performance for the year 2025, with a net profit of 108.7 million yuan.